Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
Advertisement
The Scientist
Most Recent
Genome sequence analysis confirms mobile genetic elements are a mutagenic mechanism in a variety of cancers.
Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.
A public interest legal group has renewed the fight against DNA patenting.
A small patient trial offers hope that cancer-killing viruses might be a viable therapy after all.
Exposure to doses of radiation used in some diagnostics in childhood can triple the risk of brain cancer and leukemia as an adult.
How the bacteria found in a tuberculosis vaccine can improve the outcome of bladder cancer treatment
The regulatory agency will allow early-stage breast cancer patients to try experimental drugs previously reserved for those with advanced disease.
A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
